CJC-1295 DAC 1vial/5mg Mod GRF 1-29
Long-acting GHRH analogue studied for growth-hormone pulse amplification.
- CAS
- 863288-34-0
- Dosage
- 1 vial × 5 mg
- Form
- Lyophilized powder (vial)
- Purity
- ≥99% (HPLC)
- Storage
- Store the lyophilized vial refrigerated at 2–8 °C, protected from light. Once reconstituted, keep refrigerated and use within the validated period.
- Formula
- C165H269N47O46
- Mol. weight
- 3647.2 g/mol
- Sequence
- Tyr-D-Ala-Asp-Ala-Ile-Phe-Thr-Gln-Ser-Tyr-Arg-Lys-Val-Leu-Ala-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Leu-Ser-Arg-Lys(Lys)-NH2
Description
CJC-1295 is a synthetic analogue of growth-hormone-releasing hormone (GHRH) based on the modified GRF (1-29) fragment. Four amino-acid substitutions protect it from enzymatic degradation, and the Drug Affinity Complex (DAC) allows the molecule to bind reversibly to serum albumin — extending its half-life from minutes to several days. In research models this produces a sustained elevation of growth hormone and IGF-1 while preserving the natural pulsatile release pattern, rather than flooding the system with exogenous hormone. It is frequently studied alongside a ghrelin-receptor agonist such as Ipamorelin, since the two act on complementary pathways. Supplied as a sterile lyophilized powder for reconstitution, this vial is intended exclusively for laboratory research and collector purposes.
